The board of directors of Johnson Controls International announced that John D. Young has been appointed to serve as a director.
The board of directors of
Johnson Controls International announced that John D. Young has been appointed to serve as a director. Young is currently group president of Pfizer Essential Health. Effective Jan. 1, 2018, he will become group president of Pfizer Innovative Health, which comprises six business groups focused on improving health through innovative products covering every stage of life.
Young, a scientist by background, has more than 30 years of experience with Pfizer, starting as a sales representative and moving on to a number of senior global positions across the company.
"John brings to us strong leadership across various disciplines characterized by a distinguished career leading innovative healthcare solutions across the globe," said George Oliver, chairman and CEO, Johnson Controls.
Young graduated from Glasgow University with a bachelor's degree in biological science and has a master of business administration degree from Strathclyde Graduate Business School.
The Johnson Controls board of directors also announced current director and United Parcel Service Inc. Chairman and CEO David Abney intends to retire as a director at the conclusion of the company's 2018 annual meeting of stockholders.
"I want to thank David for his years of dedicated service and wise counsel to me and our executive management team," said Oliver. "David's extensive experience as CEO of a leading global brand has been invaluable as we continue the integration efforts following last year's merger between Johnson Controls and Tyco."